Oxaliplatin Completed Phase 2 Trials for Rectal Adenocarcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01554059Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients